2026 · 3rd Quarter (July 1 - Sep 30)

AMERICAN DIABETES ASSOCIATION

Filed by AMERICAN DIABETES ASSOCIATION.

Open official filing

Source-reported fields

Filing overview

Type: 3rd Quarter - Report
Posted: Oct 20, 2026
Income: Not reported
Expenses: $100,000.00
Registrant: AMERICAN DIABETES ASSOCIATION
Client: AMERICAN DIABETES ASSOCIATION
Filing UUID: 18faf2cd-68a7-491b-ac6a-099ff4f5f66c
Termination date: Not reported

Expense method: A

Literal source text

Lobbying issues and bill citations

HCR · Health Issues

SAFE Drugs Act (H.R.6509/ S.3794); Diabetes Act (S. 4037) and competitive bidding program; INSULIN Act (H.R. 10227/ S. 4189); Diabetes foot health (H.R. 7905/H.R. 1616/S. 4070/ S. 1805); Childhood Diabetes Reduction Act (S. 5026); Special Diabetes Program Reauthorization (NIH and IHS); Appropriations for National Institutes of Health and Centers for Disease Control and Prevention; Issues related to insurance reform.

Literal federal measure citations: H.R.6509, S.3794, S. 4037, H.R. 10227, S. 4189, H.R. 7905, H.R. 1616, S. 4070, S. 1805, S. 5026

Relationship and amount limits

Bill links use only the filing year’s mathematically derived Congress plus the literal measure type and number in the issue description. Unmatched citations remain plain text. Politically.com does not join on names, infer advocacy positions, combine amendments, or calculate totals across filings.